109 related articles for article (PubMed ID: 35777800)
21. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
Qiu HB; Yang K; Yu HY; Liu M
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of the long noncoding RNA GAS5-AS1 contributes to tumor metastasis in non-small cell lung cancer.
Wu Y; Lyu H; Liu H; Shi X; Song Y; Liu B
Sci Rep; 2016 Aug; 6():31093. PubMed ID: 27489122
[TBL] [Abstract][Full Text] [Related]
23. The lncRNA
Liu C; Li H; Yin Q
Open Med (Wars); 2020; 15(1):1184-1192. PubMed ID: 33336075
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA
Hao X; Zhang M; Gu M; Wang Z; Zhou S; Li W; Xu S
PeerJ; 2022; 10():e13871. PubMed ID: 36032951
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding MELTF Antisense RNA 1 promotes and prognosis the progression of non-small cell lung cancer by targeting miR-1299.
Chai J; Qin L; Zhang G; Hua P; Jin C
Bioengineered; 2022 Apr; 13(4):10594-10604. PubMed ID: 35441579
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression.
Huang H; Yang C; Zhang Q; Zhuo T; Li X; Li N; Zhu L; Luo C; Gan J; Wu Y
Bioengineered; 2022 Mar; 13(3):4964-4977. PubMed ID: 35164653
[TBL] [Abstract][Full Text] [Related]
27. FOXD3-AS1 suppresses the progression of non-small cell lung cancer by regulating miR-150/SRCIN1axis.
Ji T; Zhang Y; Wang Z; Hou Z; Gao X; Zhang X
Cancer Biomark; 2020; 29(3):417-427. PubMed ID: 32924985
[TBL] [Abstract][Full Text] [Related]
28. LncRNA MAFG-AS1 facilitates the migration and invasion of NSCLC cell via sponging miR-339-5p from MMP15.
Jia YC; Wang JY; Liu YY; Li B; Guo H; Zang AM
Cell Biol Int; 2019 Apr; 43(4):384-393. PubMed ID: 30599080
[TBL] [Abstract][Full Text] [Related]
29. ZEB1-AS1 is associated with poor prognosis in non-small-cell lung cancer and influences cell migration and apoptosis by repressing ID1.
Jin J; Wang H; Si J; Ni R; Liu Y; Wang J
Clin Sci (Lond); 2019 Jan; 133(2):381-392. PubMed ID: 30626729
[TBL] [Abstract][Full Text] [Related]
30. [Knockdown of long non-coding RNA actin filament-associated protein 1 antisense RNA1 (AFAP1-AS1) inhibits epithelial-mesenchymal transition, invasion and migration of TPC-1 papillary thyroid cancer cells].
Fan H; Dong Q; Yu J; Yin L; Sun X; Yang X; Zhang W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Jan; 37(1):54-60. PubMed ID: 33441229
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA MCM3AP antisense RNA 1 promotes non-small cell lung cancer progression through targeting microRNA-195-5p.
Shen D; Li J; Tao K; Jiang Y
Bioengineered; 2021 Dec; 12(1):3525-3538. PubMed ID: 34346845
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA TMCC1-AS1 predicts poor prognosis and accelerates epithelial-mesenchymal transition in liver cancer.
Chen C; Su N; Li G; Shen Y; Duan X
Oncol Lett; 2021 Nov; 22(5):773. PubMed ID: 34589152
[TBL] [Abstract][Full Text] [Related]
33. LncRNA ADAMTS9-AS1, as prognostic marker, promotes cell proliferation and EMT in colorectal cancer.
Chen W; Tu Q; Yu L; Xu Y; Yu G; Jia B; Cheng Y; Wang Y
Hum Cell; 2020 Oct; 33(4):1133-1141. PubMed ID: 32918700
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
Xu C; Cui H; Li H; Wu Y; An H; Guo C
J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
[TBL] [Abstract][Full Text] [Related]
35. LncRNA NBR2 inhibits EMT progression by regulating Notch1 pathway in NSCLC.
Gao YP; Li Y; Li HJ; Zhao B
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7950-7958. PubMed ID: 31599420
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
Sun M; Liu XH; Wang KM; Nie FQ; Kong R; Yang JS; Xia R; Xu TP; Jin FY; Liu ZJ; Chen JF; Zhang EB; De W; Wang ZX
Mol Cancer; 2014 Mar; 13():68. PubMed ID: 24655544
[TBL] [Abstract][Full Text] [Related]
37. LncRNA GATA6-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer via Repressing microRNA-543 to Up-Regulating RKIP.
Gong Z; Chen X; Zhang Y; Liu C; Wang Z; Xu X; Zhu J; Xue T
Cancer Manag Res; 2020; 12():9327-9338. PubMed ID: 33061622
[TBL] [Abstract][Full Text] [Related]
38. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
Huang Y; Ni R; Wang J; Liu Y
Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
[TBL] [Abstract][Full Text] [Related]
39. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis.
Luo X; Zhou J; Quan L; Liang Y; Huang P; Chen F; Liu S
Pathol Res Pract; 2020 Nov; 216(11):153157. PubMed ID: 32858372
[TBL] [Abstract][Full Text] [Related]
40. Long Noncoding RNA FGD5-AS1 Knockdown Decrease Viability, Migration, and Invasion of Non-Small Cell Lung Cancer (NSCLC) Cells by Regulating the MicroRNA-944/MACC1 Axis.
Lv J; Li Q; Ma R; Wang Z; Yu Y; Liu H; Miao Y; Jiang S
Technol Cancer Res Treat; 2021; 20():1533033821990090. PubMed ID: 33550920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
